Stocks
Axsome Therapeutics (AXSM) EV/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -18.0 | -17.3 | -15.2 | -14.4 | -53.6 | -49.6 | ||
| Changes by years, y/y, % | +62% | -4% | -12% | -5% | +271% | +12.9% | |||
Axsome Therapeutics. EV/EBITDA
Axsome Therapeutics. EV/EBITDA, changes, %
Axsome Therapeutics (AXSM) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -21.4 | -22.2 | -28.1 | -55.1 | -49.6 | -49.6 | |
| Changes by years, y/y, % | +68% | +79% | +100% | +277% | +132% | |||
| Changes by quarters, q/q, % | +46% | +4% | +27% | +96% | -10% | |||
